Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections

INTRODUCTION: ‘Real-world’ data for mold-active triazoles (MATs) in the treatment of invasive fungal infections (IFIs) are lacking. This study evaluated usage of MATs in a disease registry for the management of IFIs. METHODS: Data were collected for this multicenter, observational, prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostrosky-Zeichner, L., Nguyen, M. H., Bubalo, J., Alexander, B. D., Miceli, M. H., Pappas, P. G., Jiang, J., Song, Y., Thompson, G. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334502/
https://www.ncbi.nlm.nih.gov/pubmed/35716251
http://dx.doi.org/10.1007/s40121-022-00661-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334502/
https://www.ncbi.nlm.nih.gov/pubmed/35716251
http://dx.doi.org/10.1007/s40121-022-00661-5

Ejemplares similares